Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last 1,333 GBp
Change Today -5.50 / -0.41%
Volume 9.4M
GSK On Other Exchanges
New York
As of 11:35 AM 07/27/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Andrew Philip Witty

Chief Executive Officer, Executive Director, Member of Corporate Administration & Transactions Committee and Member of Finance Committee, GlaxoSmithKline plc
AgeTotal Calculated CompensationThis person is connected to 12 board members in 1 different organizations across 6 different industries.

See Board Relationships
503,891,000 GBP
As of Fiscal Year 2014


Sir Andrew Philip Witty has been the Chief Executive Officer at GlaxoSmithKline plc (GSK Plc) since May 21, 2008. Mr. Witty served as the Chief Executive Officer of GlaxoSmithKline Consumer Nigeria plc. Sir Witty served as the President of Pharmaceuticals Europe at GlaxoSmithKline Plc since January 2003 and also served as its Chief Executive Officer Designate since October 2007. He served as a Senior Vice President of Asia Pacific at Pharmaceuticals International since ...

Read Full Background

Corporate Headquarters*

980 Great West Road
Brentford, Middlesex TW8 9GS

United Kingdom

Phone: 44 20 8047 5000
Fax: --

Board Members Memberships*

Former Director
Former Lead Non-Executive Board Member
Chief Executive Officer, Executive Director, Member of Corporate Administration & Transactions Committee and Member of Finance Committee


Nottingham University

Other Affiliations*

Annual Compensation*

Salary1,087,000 GBP
Bonus917,000 GBP
Total Annual Compensation2,004,000 GBP

Stock Options*

Long Term Incentive Plan1,146,000 GBP
All Other Compensation741,000 GBP
Exercised Options229,481
Exercised Options Value1,564,776 GBP
Exercisable Options89,993
Total Value of Options1,564,775 GBP
Total Number of Options319,474

Total Compensation*

Total Annual Cash Compensation2,745,000 GBP
Total Short Term Compensation2,004,000 GBP
Other Long Term Compensation741,000 GBP
Total Calculated Compensation3,891,000 GBP
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
GSK:LN 1,333.00 GBp -5.50


Omar S. Ishrak Chairman and Chief Executive Officer
Medtronic plc
Robert J. Hugin MBAChairman, Chief Executive Officer and Chairman of Executive Committee
Celgene Corporation
John C. Lechleiter Ph.D.Chairman, Chief Executive Officer and President
Eli Lilly and Company
Inge G. Thulin Chairman, Chief Executive Officer and President
3M Company
Richard A. Gonzalez Chairman, Chief Executive Officer and Chairman of Executive Committee
AbbVie Inc.
Compensation as of Fiscal Year 2015.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact GLAXOSMITHKLINE PLC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at